Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imunon
Biotech
Neumora overhauls C-suite after phase 3 flop—Chutes & Ladders
Neumora overhauls C-suite after phase 3 flop. Lycia lands veteran CMO. Navigator arrives at new CEO.
Darren Incorvaia
,
Zoey Becker
Feb 14, 2025 8:30am
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
May 10, 2024 8:30am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Dec 15, 2023 9:30am
Celsion rebrands to Imunon to reflect immunotherapy plans
Sep 20, 2022 7:20am
